Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

0(0%)

Results Posted

50%(1 trials)

Terminated

1(33%)

Phase Distribution

Ph not_applicable

67%

Ph phase_2

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 2Efficacy & side effects

1(33.3%)

N/ANon-phased studies

2(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Terminated(1)

Detailed Status

Completed2

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 2

Trials by Phase

Phase 21 (33.3%)

N/A2 (66.7%)

Trials by Status

completed267%

terminated133%

Recent Activity

0 active trials

Showing 3 of 3

terminatednot_applicable

Non-invasive Brain Stimulation in Adults Who Stutter

NCT03437512

completedphase_2

Implementation Intentions for Weight Loss and Dietary Change in College Students With Overweight and Obesity

NCT04105309

completednot_applicable

Enhancing Speech Fluency With Non-invasive Brain Stimulation in Developmental Stuttering

NCT02288598

Clinical Trials (3)

Showing 3 of 3 trials

NCT03437512Not Applicable

Non-invasive Brain Stimulation in Adults Who Stutter

Terminated

NCT04105309Phase 2

Implementation Intentions for Weight Loss and Dietary Change in College Students With Overweight and Obesity

Completed

NCT02288598Not Applicable

Enhancing Speech Fluency With Non-invasive Brain Stimulation in Developmental Stuttering

Completed

All 3 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 3